Home/Filings/4/0000899243-17-019998
4//SEC Filing

BULLOCK LAWRENCE E 4

Accession 0000899243-17-019998

CIK 0001273636other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 9:54 PM ET

Size

5.7 KB

Accession

0000899243-17-019998

Insider Transaction Report

Form 4
Period: 2017-08-03
BULLOCK LAWRENCE E
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-03+4,1684,168 total
    Exercise: $4.50Exp: 2027-08-03Common Stock (4,168 underlying)
Footnotes (1)
  • [F1]Option became exercisable for 25% on August 3, 2017, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments on the last day of each calendar month beginning August 31, 2017 and ending October 31, 2017, as long as Mr. Bullock continues to be employed with Applied Genetic Technologies Corporation and with no further vesting after his employment ends.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001206868

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 9:54 PM ET
Size
5.7 KB